Aspen Pharmacare Holdings Ltd (APN) — Cash Flow Reinvestment Rate
Aspen Pharmacare Holdings Ltd (APN) has a Cash Flow Reinvestment Rate of 0.32x as of December 2025, reinvesting ZAC1.13 Billion (capex ZAC1.13 Billion ) from operating cash flow of ZAC3.58 Billion. See Aspen Pharmacare Holdings Ltd (APN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aspen Pharmacare Holdings Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Aspen Pharmacare Holdings Ltd across 23 annual periods. For the full cash flow conversion analysis, see APN operating cash flow.
Annual Cash Flow Reinvestment Rate for Aspen Pharmacare Holdings Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Aspen Pharmacare Holdings Ltd. See financial agility of Aspen Pharmacare Holdings Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (ZAC) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.99x | ZAC10.27 Billion | ZAC5.16 Billion | ZAC5.05 Billion | ▼ -17.4% |
| 2024 | 2.41x | ZAC15.00 Billion | ZAC6.22 Billion | ZAC5.54 Billion | ▲ +101.5% |
| 2023 | 1.20x | ZAC6.60 Billion | ZAC5.52 Billion | ZAC3.18 Billion | ▲ +32.3% |
| 2022 | 0.90x | ZAC4.86 Billion | ZAC5.37 Billion | ZAC2.70 Billion | ▼ -53.2% |
| 2021 | 1.93x | ZAC13.19 Billion | ZAC6.83 Billion | ZAC3.43 Billion | ▲ +270.1% |
| 2020 | 0.52x | ZAC4.31 Billion | ZAC8.26 Billion | ZAC2.69 Billion | ▼ -54.0% |
| 2019 | 1.14x | ZAC6.82 Billion | ZAC6.00 Billion | ZAC3.58 Billion | ▼ -62.1% |
| 2018 | 3.00x | ZAC21.04 Billion | ZAC7.02 Billion | ZAC8.23 Billion | ▲ +634.9% |
| 2017 | 0.41x | ZAC2.65 Billion | ZAC6.50 Billion | ZAC2.60 Billion | ▼ -66.5% |
| 2016 | 1.22x | ZAC3.90 Billion | ZAC3.20 Billion | ZAC2.80 Billion | ▲ +125.3% |
| 2015 | 0.54x | ZAC2.62 Billion | ZAC4.84 Billion | ZAC2.42 Billion | ▼ -6.9% |
| 2014 | 0.58x | ZAC2.23 Billion | ZAC3.84 Billion | ZAC2.03 Billion | ▼ -46.4% |
| 2013 | 1.08x | ZAC4.32 Billion | ZAC3.99 Billion | ZAC4.32 Billion | ▲ +20.4% |
| 2012 | 0.90x | ZAC2.62 Billion | ZAC2.91 Billion | ZAC2.62 Billion | ▲ +162.1% |
| 2011 | 0.34x | ZAC840.20 Million | ZAC2.45 Billion | ZAC840.20 Million | ▼ -46.0% |
| 2010 | 0.64x | ZAC1.29 Billion | ZAC2.03 Billion | ZAC1.29 Billion | ▼ -79.0% |
| 2009 | 3.02x | ZAC3.91 Billion | ZAC1.29 Billion | ZAC3.91 Billion | ▲ +261.7% |
| 2008 | 0.84x | ZAC545.32 Million | ZAC652.38 Million | ZAC545.32 Million | ▲ +37.1% |
| 2007 | 0.61x | ZAC431.95 Million | ZAC708.56 Million | ZAC431.95 Million | ▼ -20.1% |
| 2006 | 0.76x | ZAC307.02 Million | ZAC402.21 Million | ZAC307.02 Million | ▲ +191.2% |
| 2005 | 0.26x | ZAC167.26 Million | ZAC638.20 Million | ZAC167.26 Million | ▼ -45.0% |
| 2004 | 0.48x | ZAC237.75 Million | ZAC498.74 Million | ZAC237.75 Million | ▼ -29.6% |
| 2003 | 0.68x | ZAC261.27 Million | ZAC385.95 Million | ZAC261.27 Million | — |